Ac-ETDK(myr)-AMC
Ac-ETDK(myr)-AMC is a DLAT-derived ε-N-myristoyllysine peptide substrate for fatty-acid deacylase HDAC11, used in fluorescence-based HDAC11 activity assays. Ac-ETDK(myr)-AMC undergoes cleavage of ε-N-myristoyllysine by HDAC11, followed by trypsin-mediated cleavage of C-terminal lysine to release measurable fluorophore AMC.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1857308-95-2
- 分子式: C45H68N6O13
- 分子量:901.05
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[1]|
HDAC-11 |
体外実験
Ac-ETDK(myr)-AMC serves as an efficient ε-N-myristoyllysine substrate for recombinant human HDAC11 in an AMC-based fluorescence activity assay[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
化学情報
-
CAS 番号 1857308-95-2
-
分子量 901.05
-
分子式 C45H68N6O13
-
SMILES
CC(C1=CC=C(NC([C@H](CCCCNC(CCCCCCCCCCCCC)=O)NC([C@H](CC(O)=O)NC([C@H]([C@H](O)C)NC([C@@H](NC(C)=O)CCC(O)=O)=O)=O)=O)=O)C=C1O2)=CC2=O
-
配列
Ac-Glu-Thr-Asp-Lys(myr)-AMC
-
シーケンスの短縮
Ac-ETDK(myr)-AMC
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Cuproptosis Solutions
Cuproptosis is a copper-dependent regulated cell-death pathway in which intracellular copper binds lipoylated tricarboxylic acid cycle proteins, especially DLAT-containing pyruvate dehydrogenase complex components, causing lipoylated protein aggregation, iron-sulfur cluster protein loss, proteotoxic stress, and cell death. The pathway is functionally linked to mitochondrial respiration because copper-ionophore sensitivity is higher in cells dependent on oxidative phosphorylation, and FDX1 and protein lipoylation machinery are required for copper-ionophore-induced death. Elesclomol-Cu and related copper-loading strategies are widely used experimental tools to induce cuproptosis, whereas copper chelation with tetrathiomolybdate or genetic suppression of FDX1, LIAS, LIPT1, or DLAT can test pathway dependence. The major unresolved questions are how disease context determines cuproptosis sensitivity, how copper transporters such as SLC31A1/CTR1 and ATP7A/ATP7B regulate the pathway, and whic
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)